Back to Search
BRAD SPELLBERG M.D.
M.D.
Infectious Disease Physician
NPI: 1720132475Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
A73048(CA)
Research & Publications (20)
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.
PMID 19555285·Clin Infect Dis·2009
1-meta
Recent advances in the management of mucormycosis: from bench to bedside.
PMID 19435437·Clin Infect Dis·2009
6-review
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis.
PMID 19433555·Antimicrob Agents Chemother·2009
8-other
Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumonia.
PMID 18986274·Clin Infect Dis·2008
8-other
The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus.
PMID 18644876·Infect Immun·2008
7-preclinical
Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.
PMID 18419471·J Infect Dis·2008
7-preclinical
Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge.
PMID 18282100·PLoS Pathog·2008
7-preclinical
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
PMID 18171244·Clin Infect Dis·2008
8-other
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
PMID 17565458·Infection·2007
8-other
Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts.
PMID 17158608·J Leukoc Biol·2007
7-preclinical
Current treatment strategies for disseminated candidiasis.
PMID 16355336·Clin Infect Dis·2006
6-review
Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
PMID 16779733·J Infect Dis·2006
7-preclinical
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
PMID 16020690·Clin Microbiol Rev·2005
6-review
Mice with disseminated candidiasis die of progressive sepsis.
PMID 15962230·J Infect Dis·2005
7-preclinical
A phagocytic cell line markedly improves survival of infected neutropenic mice.
PMID 15857941·J Leukoc Biol·2005
7-preclinical
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
PMID 15673781·Antimicrob Agents Chemother·2005
7-preclinical
The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
PMID 16113347·Infect Immun·2005
7-preclinical
Trends in antimicrobial drug development: implications for the future.
PMID 15127341·Clin Infect Dis·2004
8-other
Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
PMID 15317746·J Antimicrob Chemother·2004
5-case
Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.
PMID 14500497·Infect Immun·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 W CARSON ST
TORRANCE, CA 90502 - Phone
- (310) 222-3813
Quick Facts
- NPI
- 1720132475
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile